Clinical Trial Update: Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis [Phase 2]

View source ↗

Summary

Phase 2 trial of AST-120 for antibiotic-refractory pouchitis was terminated; the update discusses safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pouchitis

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Ocera Therapeutics | Conditions: Pouchitis | Phase 2 | Status: TERMINATED